Skip to Main Content
Try STAT+ TODAY
Trending:
The Obesity Revolution
Health
Biotech
STAT+
Subscribe Now To access exclusive content, subscribe to STAT+
View Latest View the latest STAT+ stories
Biotech
STAT+

The big drug lobby isn’t criticizing Trump’s budget. That’s angering industry insiders

  • Damian Garde

By Damian Garde March 16, 2017

Reprints
Stephen Ubl & Trump
President Trump listens to PhRMA president Stephen Ubl during a meeting at the White House in January. Ron Sachs/Getty Images

The National Institutes of Health is staring down a proposed $6 billion budget cut that could slash funding for biomedical research. The response from the drug industry’s largest lobbying group?

Let’s call it tepid.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED

About the Author Reprints

Damian Garde

Damian Garde

National Biotech Reporter

Damian Garde covers biotech, is a co-writer of The Readout newsletter, and a co-host of "The Readout LOUD" podcast.

Tags

Texas judge strikes down major Obamacare provision protecting preventive…
Texas judge strikes down major Obamacare provision protecting preventive care
Former J&J exec, an in-demand free agent, takes the…
Former J&J exec, an in-demand free agent, takes the helm at privately held FogPharma
Dutch health minister won’t cover a Gilead cancer drug…
Dutch health minister won’t cover a Gilead cancer drug due to the cost
Solicitor general urges Supreme Court to review ‘skinny labeling’…
Solicitor general urges Supreme Court to review ‘skinny labeling’ and generic drug access
Drug middlemen switch tactics, but the outcome is the…
Drug middlemen switch tactics, but the outcome is the same: high prices
Listen: Biotech’s monkey shortage, the broken generics market, &…
Listen: Biotech’s monkey shortage, the broken generics market, & conference cancel culture

Recommended Stories